Dry eye disease
Conditions
Brief summary
Changes in dry eye symptoms from baseline to 6 months after treatment time
Detailed description
Change of corneal staining from baseline to 6 months after treatment, Change in corneal aesthesiometry from baseline to 6 months after treatment, Change in conjunctival hyperemia from baseline to 6 months after treatment, Change in non-invasive tear film break-up time from baseline to 6 months after treatment, Change in light dispersion from baseline to 6 months after treatment, Change in cytokine levels from baseline to 6 months after treatment, Changes in therapeutic compliance with hypotensive treatment, Proportion of patients presenting adverse effects
Interventions
Sponsors
Hospital Clinico San Carlos
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in dry eye symptoms from baseline to 6 months after treatment time | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of corneal staining from baseline to 6 months after treatment, Change in corneal aesthesiometry from baseline to 6 months after treatment, Change in conjunctival hyperemia from baseline to 6 months after treatment, Change in non-invasive tear film break-up time from baseline to 6 months after treatment, Change in light dispersion from baseline to 6 months after treatment, Change in cytokine levels from baseline to 6 months after treatment, Changes in therapeutic compliance with hypotensive treatment, Proportion of patients presenting adverse effects | — |
Countries
Spain
Outcome results
None listed